Sectors

Lilly Asia Ventures has returned to co-lead the cancer immunotherapy developer’s series C round with Greater Bay Area Homeland Investments.

Novo, Sanofi and Merck & Co all scored exits as the cancer drug developer, which had been spun off by Biox Biosciences, floated in a $101m offering.

Access Biotechnology is among the initial investors disclosed by Eliem Therapeutics, which is targeting neuronal excitability disorders.

SoftBank Ventures Asia and Bangkok Bank were among the investors that added $65m to the online share trading platform's series A round.

The business service provider has added $40m to the round's Stripe-backed first close, doubling its valuation to $1.2bn in the process.

The truck management platform developer increased its overall funding to $31m in a series B round featuring Axa Venture Partners.

The $27.5m round was led by PayU and included another of the e-commerce platform's existing investors, Info Edge Ventures, as well as Google.

The Finaves-backed developer of brain implant technology based on research from University of Manchester has secured series A funding.

SoftBank-backed co-working space provider WeWork will finally get a public listing, at a $9bn initial enterprise value.

The Alphabet and Tencent-backed automation software producer, valued at $35bn as of last month, has filed for a $1bn offering.

The Lockheed Martin-backed satellite launch system developer has now raised at least $219m of funding ahead of its first official launch.